Login / Signup
Samareh Heydari
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Interstitial Lung Disease
Ejection Fraction
Prognostic Factors
Patient Reported Outcomes
Top Venues
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sadaf Alipour
,
Bardia Gholami
,
Marzieh Orouji
,
Samareh Heydari
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
32 (1) (2023)
Sadaf Alipour
,
Bardia Gholami
,
Marzieh Orouji
,
Samareh Heydari
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
32 (1) (2023)
Sadaf Alipour
,
Bardia Gholami
,
Marzieh Orouji
,
Samareh Heydari
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
(2023)
Sadaf Alipour
,
Bardia Gholami
,
Marzieh Orouji
,
Samareh Heydari
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
32 (1) (2023)
Sadaf Alipour
,
Bardia Gholami
,
Marzieh Orouji
,
Samareh Heydari
Imiquimod as a new treatment in refractory idiopathic granulomatous mastitis: report of two cases.
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
32 (1) (2023)